General Information of Drug Transporter (DT)
DT ID DTD0124 Transporter Info
Gene Name SLC18A3
Transporter Name Vesicular acetylcholine transporter
Gene ID
6572
UniProt ID
Q16572

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        CREB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC18A3 gene [1]

TF Protein Name

Cyclic AMP-responsive element-binding protein 1 Transcription Factor Info

Tissue

Liver; Uterus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC18A3 gene, which in turn affects the expression or function of the drug transporter Vesicular acetylcholine transporter.

      Class 1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        HAND2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Repression of SLC18A3 gene in health condition [2]

TF Protein Name

Heart- and neural crest derivatives-expressed protein 2 Transcription Factor Info

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Nerve

Related DT Changes

Down regulating

Experimental Material

Chick

Detailed Description

Heart- and neural crest derivatives-expressed protein 2 (HAND2) has been reported to repress the transcription of SLC18A3 gene in health condition, which leads to a decreased expression of the drug transporter Vesicular acetylcholine transporter.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        SATB2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC18A3 gene in health condition [3]

TF Protein Name

DNA-binding protein SATB2 Transcription Factor Info

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Nerve

Related DT Changes

Up regulating

Experimental Material

Rat superior cervical ganglia isolates

Detailed Description

DNA-binding protein SATB2 (SATB2) has been reported to activate the transcription of SLC18A3 gene in health condition, which leads to an increased expression of the drug transporter Vesicular acetylcholine transporter.

TF Superclass 6: Immunoglobulin fold

      Class 6.2: STAT domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        STAT3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC18A3 gene in alzheimer disease condition [4]

TF Protein Name

Signal transducer and activator of transcription 3 Transcription Factor Info

Studied Phenotype

Alzheimer disease [ICD11: 8A20]

Tissue

Brain

Related DT Changes

Up regulating

Experimental Material

CD-1 mice

Detailed Description

Signal transducer and activator of transcription 3 (STAT3) has been reported to activate the transcription of SLC18A3 gene in alzheimer disease condition, which leads to an increased expression of the drug transporter Vesicular acetylcholine transporter.
References
1 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-434. (ID:ENSG00000187714)
2 The bHLH transcription factor Hand2 is essential for the maintenance of noradrenergic properties in differentiated sympathetic neurons. Dev Biol. 2009 May 15;329(2):191-200.
3 The sympathetic neurotransmitter switch depends on the nuclear matrix protein Satb2. J Neurosci. 2010 Dec 1;30(48):16356-64.
4 Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease. Neuropsychopharmacology. 2008 Jul;33(8):2020-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.